Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

NCT06928922 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Advanced Lung Cancer
Lung Metastasis

Interventions

BIOLOGICAL: BMD006 monotreatment
BIOLOGICAL: BMD006 in combination with PD-1 antibody
BIOLOGICAL: BMD006 in combination with PD-1/VEGF antibody

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences